ArticlePloS one2026

Secretory leukocyte protease inhibitor (SLPI) promotes cholangiocarcinoma progression via inflammation-associated and vasculogenic mechanisms.

Kangsadan Chueajedton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.